Back to Journals » International Journal of Nanomedicine » Volume 6

Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles

Authors Rodriguez HL, Latorre-Esteves M, Mendez J , Soto O, Rodriguez AR, Rinaldi C , Torres-Lugo M

Published 15 February 2011 Volume 2011:6 Pages 373—380


Review by Single anonymous peer review

Peer reviewer comments 4

Héctor L Rodríguez-Luccioni, Magda Latorre-Esteves, Janet Méndez-Vega, Orlando Soto, Ana R Rodríguez, Carlos Rinaldi, Madeline Torres-Lugo
Department of Chemical Engineering, University of Puerto Rico, Mayagüez 00681, Puerto Rico

Abstract: Colloidal suspensions of iron oxide magnetic nanoparticles are known to dissipate energy when exposed to an oscillating magnetic field. Such energy dissipation can be employed to locally raise temperature inside a tumor between 41°C and 45°C (hyperthermia) to promote cell death, a treatment known as magnetic fluid hyperthermia (MFH). This work seeks to quantify differences between MFH and hot-water hyperthermia (HWH) in terms of reduction in cell viability using two cancer cell culture models, Caco-2 (human epithelial colorectal adenocarcinoma) and MCF-7 (human breast cancer). Magnetite nanoparticles were synthesized via the co-precipitation method and functionalized with adsorbed carboxymethyl dextran. Cytotoxicity studies indicated that in the absence of an oscillating magnetic field, cell viability was not affected at concentrations of up to 0.6 mg iron oxide/mL. MFH resulted in a significant decrease in cell viability when exposed to a magnetic field for 120 minutes and allowed to rest for 48 hours, compared with similar field applications, but with shorter resting time. The results presented here suggest that MFH most likely induces apoptosis in both cell types. When compared with HWH, MFH produced a significant reduction in cell viability, and these effects appear to be cell-type related.

Keywords: magnetic fluid hyperthermia, carboxymethyl dextran magnetite, cell death, apoptosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.